» Articles » PMID: 27017252

The Controversial Role of Human Chorionic Gonadotropin in the Development of Breast Cancer and Other Types of Tumors

Overview
Journal Breast
Publisher Elsevier
Specialties Endocrinology
Oncology
Date 2016 Mar 28
PMID 27017252
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Breast cancer is the most often diagnosed tumor of women and one of the leading cause of cancer related death. Due to different known risk factors there are epidemiological differences. Beside genetic disorders and patient's age it is especially the age of the first full-term pregnancy and in this context the pregnancy hormone human chorionic gonadotropin that seems to play an important role.

Methods: This review is based on a PubMed research in publications of the last 20 years. Only articles in English language were considered.

Results: The effect of human chorionic gonadotropin on development of cancer is controversial. In fact, for breast cancer there is evidence that this hormone has a protective effect against tumorigenesis due the differentiation of the mammary tissue after a full term pregnancy through the downregulation of estrogen receptors.

Conclusion: Human chorionic gonadotropin has among promoting pregnancy important controversial functions especially in tumor development. The mechanisms that explain the pro- and anti-carcinogenic effects are not fully understood yet. It seems to have a protective effect on breast cancer through increasing differentiation and hereby decreasing susceptibility of the mammary tissue for toxicants. This knowledge might help developing a preventive agent in the next future that uses the anti-carcinogenic effect of human chorionic gonadotropin and thereby decrease the mortality out of breast cancer.

Citing Articles

Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review).

Chang C, Chen Y, Wang Y, Chen H, Hsu C, Lin K Oncol Rep. 2024; 51(3).

PMID: 38240107 PMC: 10823338. DOI: 10.3892/or.2024.8701.


The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.

Sjoblom A, Carpen T, Stenman U, Jouhi L, Haglund C, Syrjanen S Cancers (Basel). 2022; 14(12).

PMID: 35740496 PMC: 9221036. DOI: 10.3390/cancers14122830.


ameliorates ovarian and uterine oxido-inflammatory responses in -methyl--nitrosourea and benzo[a]pyrene-treated rats.

Adefisan A, Madu J, Owumi S, Adaramoye O Exp Biol Med (Maywood). 2020; 245(16):1490-1503.

PMID: 32746633 PMC: 7553087. DOI: 10.1177/1535370220947387.


β-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue.

Sengodan S, Hemalatha S, Nadhan R, Somanathan T, Mathew A, Chil A Carcinogenesis. 2019; 40(11):1415-1426.

PMID: 30963174 PMC: 7175285. DOI: 10.1093/carcin/bgz070.


Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo.

Yazdian-Robati R, Ramezani M, Jalalian S, Abnous K, Taghdisi S Pharm Res. 2016; 33(9):2289-97.

PMID: 27283831 DOI: 10.1007/s11095-016-1967-4.